APOE Gene Alzheimer Disease Type 2 Genetic Test
Test Details
The APOE gene is a gene that provides instructions for making a protein called apolipoprotein E. This protein is involved in the metabolism of lipids (fats) in the body, including cholesterol. The APOE gene has three common variants, called 2, 3, and 4. These variants differ in the amino acid sequence of the apolipoprotein E protein they produce.
The APOE 4 variant has been associated with an increased risk of developing Alzheimer’s disease, particularly late-onset Alzheimer’s disease (the most common form of the disease). Individuals who inherit one copy of the APOE 4 variant have an increased risk of developing Alzheimer’s disease, while those who inherit two copies of the variant have an even higher risk.
NGS (next-generation sequencing) genetic testing can be used to analyze an individual’s APOE gene and determine which variants they carry. This information can be used to assess an individual’s risk of developing Alzheimer’s disease and inform medical decision-making. However, it’s important to note that having the APOE 4 variant does not mean that an individual will definitely develop Alzheimer’s disease, and not having the variant does not guarantee that an individual will not develop the disease. Other genetic and environmental factors also play a role in the development of Alzheimer’s disease.
Test Name
APOE Gene Alzheimer Disease Type 2 Genetic Test
Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Clinical History of Patient who is going for APOE Gene Alzheimer Disease Type 2 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Alzheimer Disease Type 2
| Test Name | APOE Gene Alzheimer disease type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for APOE Gene Alzheimer disease type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with APOE Gene Alzheimer disease type 2 |
| Test Details | The APOE gene is a gene that provides instructions for making a protein called apolipoprotein E. This protein is involved in the metabolism of lipids (fats) in the body, including cholesterol. The APOE gene has three common variants, called 2, 3, and 4. These variants differ in the amino acid sequence of the apolipoprotein E protein they produce. The APOE 4 variant has been associated with an increased risk of developing Alzheimer’s disease, particularly late-onset Alzheimer’s disease (the most common form of the disease). Individuals who inherit one copy of the APOE 4 variant have an increased risk of developing Alzheimer’s disease, while those who inherit two copies of the variant have an even higher risk. NGS (next-generation sequencing) genetic testing can be used to analyze an individual’s APOE gene and determine which variants they carry. This information can be used to assess an individual’s risk of developing Alzheimer’s disease and inform medical decision-making. However, it’s important to note that having the APOE 4 variant does not mean that an individual will definitely develop Alzheimer’s disease, and not having the variant does not guarantee that an individual will not develop the disease. Other genetic and environmental factors also play a role in the development of Alzheimer’s disease. |
